Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Cancers

Some patients with glioblastoma show a worsening presentation in imaging after concurrent chemoradiation, even when they receive gross total resection. Previously, we showed the feasibility of a machine learning model to predict pseudoprogression (PsPD) versus progressive disease (PD) in glioblastoma patients. The previous model was based on the dataset from two institutions (termed as the Seoul National University Hospital (SNUH) dataset, N = 78). To test this model in a larger dataset, we collected cases from multiple institutions that raised the problem of PsPD vs. PD diagnosis in clinics (Korean Radiation Oncology Group (KROG) dataset, N = 104). The dataset was composed of brain MR images and clinical information. We tested the previous model in the KROG dataset; however, that model showed limited performance. After hyperparameter optimization, we developed a deep learning model based on the whole dataset (N = 182). The 10-fold cross validation revealed that the micro-average area under the precision-recall curve (AUPRC) was 0.86. The calibration model was constructed to estimate the interpretable probability directly from the model output. After calibration, the final model offers clinical probability in a web-user interface.

Jang Bum-Sup, Park Andrew J, Jeon Seung Hyuck, Kim Il Han, Lim Do Hoon, Park Shin-Hyung, Lee Ju Hye, Chang Ji Hyun, Cho Kwan Ho, Kim Jin Hee, Sunwoo Leonard, Choi Seung Hong, Kim In Ah

2020-Sep-21

glioblastoma, machine learning, pseudoprogression, radiotherapy